04:37 PM EDT, 10/22/2024 (MT Newswires) -- Ryan J. Watts, Director, President and CEO, on October 18, 2024, sold 40,000 shares in Denali Therapeutics ( DNLI ) for $1,107,600. Following the Form 4 filing with the SEC, Watts has control over a total of 2,438,411 shares of the company, with 235,807 shares held directly and 2,202,604 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1714899/000171489924000206/xslF345X05/wk-form4_1729629050.xml